CLEC10A and metastatic malignant neoplasm in the lymph nodes: Notably, such associations were observed in TNBC with CD301 and in ER-positive breast cancer cases, specifically in non-special type (NST) tumors of intermediate grade (without lymph node metastases, tumor size between 0.5 cm and 2 cm) with LSECtin.